HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Endocrine Tumors

Endocrine Tumors

Endocrine tumors are a diverse group of cancers that originate in hormone-producing glands such as the thyroid, adrenal, and pancreas. They can be benign or malignant and often present challenges in diagnosis and treatment due to their varied hormonal effects. Cancer research in this field focuses on understanding the genetic and molecular mechanisms underlying tumor development, identifying biomarkers for early detection, and developing targeted therapies to improve patient outcomes. Advances in imaging technologies and molecular profiling have enabled more precise diagnosis and personalized treatment strategies. Clinical trials investigating novel therapies, including hormone receptor-targeted drugs and immunotherapies, offer hope for improved survival rates and quality of life for patients with endocrine tumors. Ongoing collaborative efforts among researchers, clinicians, and pharmaceutical companies are essential for furthering our understanding and management of these complex cancers.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp